Author： Sule Sangeeta D Wigley Fredrick M
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.3, 2003-03, pp. : 471-482
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging targets for the treatment of scleroderma
By Leask Andrew
Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. :
Access to resources
Recommend
Novel therapy in the treatment of scleroderma
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. :
Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease
Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. :
Treatment of Postherpetic Neuralgia: An Update
By Kanazi G.E.
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
Update on ocular allergy treatment
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. :